Cancer Risk from Pork Leads FDA to Withdraw Approval for Drug Used to Treat Pigs
The FDA is withdrawing approval of carbadox, a swine drug which the agency says can leave cancerous residue in pork designated for human consumption.
The FDA is withdrawing approval of carbadox, a swine drug which the agency says can leave cancerous residue in pork designated for human consumption.